1. Hereditary Gynecological Malignancy and Molecular Features
   Hideki Yamamoto et al, 2021, Molecular Diagnosis and Targeting for Gynecologic Malignancy CrossRef
2. Radiologic screening and surveillance in hereditary cancers
   Jamie E. Clarke et al, 2022, European Journal of Radiology Open CrossRef
3. Updates in gynecologic care for individuals with lynch syndrome
   Kaylee A. Underkofler et al, 2023, Frontiers in Oncology CrossRef
4. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma,
   Alexandros Rodolakis et al, 2022, Human Reproduction Open CrossRef
5. First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome
   H. Ziada-Bouchaar et al, 2017, Familial Cancer CrossRef
6. Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy
   Roberta Pastorino et al, 2020, PLOS ONE CrossRef
7. Imaging of Hereditary Tumors of the Female Genital System
   Sarah M. Rothan et al, 2017, Journal of Computer Assisted Tomography CrossRef
8. Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer
   Simav Gildiz et al, 2023, Pharmaceutical Research CrossRef
9. Hereditary ovarian tumour syndromes: current update on genetics and imaging
   K.P. Shanbhogue et al, 2021, Clinical Radiology CrossRef
10. PMS2 gene mutation results in DNA mismatch repair system failure in a case of adult granulosa cell tumor
    Wen-Chung Wang et al, 2017, Journal of Ovarian Research CrossRef
11. RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report
    Elisa Gelli et al, 2020, Frontiers in Oncology CrossRef
12. Cyberknife Radiosurgery for Prostate Cancer after Abdominoperineal Resection (CYRANO): The Combined Computer Tomography and Electromagnetic Navigation Guided Transperineal Fiducial Markers Implantation Technique
    Andrea Vavassori et al, 2023, Current Oncology CrossRef
13. Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2
    JINGWEI LI et al, 2015, Oncology Reports CrossRef
14. A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
    Shuangfeng Chen et al, 2021, Frontiers in Oncology CrossRef
15. Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma
    Elisa Schmoeckel et al, 2019, Virchows Archiv CrossRef
16. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
    Alexandros Rodolakis et al, 2023, International Journal of Gynecologic Cancer CrossRef
17. Synchronous tumours of the female reproductive tract
    C. Blake Gilks et al, 2018, Pathology CrossRef
18. Epidemiological trends and risk factors of gynecological cancers: an update
    Vahideh Keyvani et al, 2023, Medical Oncology CrossRef
19. Magic shotgun over magic bullet for treatment of ovarian cancer via polymeric nanoparticles
    Bakr Ahmed et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
20. Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer
    Ilaria Capasso et al, 2023, Cancers CrossRef
21. Mismatch Repair Deficiency in Ovarian Carcinoma
    Susanna Leskela et al, 2020, American Journal of Surgical Pathology CrossRef
22. Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
    Sanat Kulkarni et al, 2024, Frontiers in Oncology CrossRef
23. Hereditary ovarian cancers: state of the art
    Angela Toss et al, 2019, Minerva Medica CrossRef
24. Prevalence and Genotype-Phenotype Correlation of Lynch Syndrome in a Selected High-Risk Cohort from Qatar’s Population
    Mariem Sidenna et al, 2022, Genes CrossRef
25. Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
    Roopak Murali et al, 2023, Metabolites CrossRef
26. The gynecological surveillance of women with Lynch syndrome in Sweden
    Gerasimos Tzortzatos et al, 2015, Gynecologic Oncology CrossRef
27. For Women, Lynch Syndrome Is About More than Colon Cancer
    Wendy M. Parker et al, 2019, Cancer Prevention Research CrossRef
28. Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
    Sidrah Shah et al, 2022, International Journal of Environmental Research and Public Health CrossRef
29. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile
    Maria Rasmussen et al, 2021, Gynecologic Oncology CrossRef
30. The Interaction of Menopause and Chronic Disease
    Patricia Geraghty, 2022, Each Woman’s Menopause: An Evidence Based Resource CrossRef
31. Social and psychological aspects of medical and genetic counseling of patients with hereditary tumor syndromes and their relatives
    M.M. Byahova et al, 2024, null CrossRef
32. Hereditary Ovarian Cancer: Not OnlyBRCA1 and 2 Genes
    Angela Toss et al, 2015, BioMed Research International CrossRef
33. Disparities in gynecologic cancer genetics evaluation
    Emily M. Hinchcliff et al, 2019, Gynecologic Oncology CrossRef
34. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer
    John M Carethers, 2015, World Journal of Gastroenterology CrossRef
35. Germline mutations in Chinese ovarian cancer with or without breast cancer
    Ava Kwong et al, 2022, Molecular Genetics & Genomic Medicine CrossRef
36. Ovarian Cancer Surgery
    Brittany Maggard et al, 2023, Anesthesia for Oncological Surgery CrossRef
37. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
    Lucy Aitken et al, 2017, Internal Medicine Journal CrossRef
38. A Novel Mutation of MSH2 Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies
    Ugne Silinskaite et al, 2023, Journal of Clinical Medicine CrossRef
39. Imaging approaches for the diagnosis of genetic diseases affecting the female reproductive organs and beyond
    Miki Yoshida et al, 2024, Abdominal Radiology CrossRef
40. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes
    Quentin B. Nakonechny et al, 2016, Surgical Pathology Clinics CrossRef
41. Genetics
    Cindy L. Vnencak-Jones et al, 2018, Principles and Applications of Molecular Diagnostics CrossRef
42. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
    A Rodolakis et al, 2023, Facts, Views and Vision in ObGyn CrossRef
43. Fertility preservation in patients with BRCA mutations or Lynch syndrome
    Giacomo Corrado et al, 2021, International Journal of Gynecologic Cancer CrossRef
44. ERCC3, a new ovarian cancer susceptibility gene?
    Agostina Stradella et al, 2020, European Journal of Cancer CrossRef
45. ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
    A Rodolakis et al, 2023, Facts, Views and Vision in ObGyn CrossRef
46. Cutting-Edge Technologies for Ovarian Cancer: An Overview of the Impact of Genetic Testing, Next-Generation Sequencing, and Single-Cell Analysis
    Alia Ghoneum et al, 2021, Ovarian Cancer Biomarkers CrossRef
47. Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers
    Mark R. Openshaw et al, 2020, Frontiers in Digital Health CrossRef
48. An assessment of mismatch repair deficiency in ovarian tumours at a public hospital in Johannesburg, South Africa
    S R De Klerk et al, 2022, South African Journal of Obstetrics and Gynaecology CrossRef
49. Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
    Pavlina Chrysafi et al, 2023, Cancers CrossRef
50. Gynecological Cancers in Lynch Syndrome: A Comparison of the Histological Features with Sporadic Cases of the General Population
    Valentina Elisabetta Bounous et al, 2022, Journal of Clinical Medicine CrossRef
51. Opportunistic Salpingectomy at Time of Nongynecologic Elective Procedures Could Reduce Ovarian Cancer–Related Costs and Mortality
    Brittany N. Hughes et al, 2022, Journal of Gynecologic Surgery CrossRef
52. Ovarian cancer
    Tessa Thull et al, 2024, JAAPA CrossRef
53. Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists
    Malak Itani et al, 2021, Abdominal Radiology CrossRef
54. Ovarian Cancer: Molecular Classification and Targeted Therapy
    Febina Ravindran et al, 2021, Ovarian Cancer - Updates in Tumour Biology and Therapeutics [Working Title] CrossRef
55. The Gene Expression and Mutations in Ovarian Cancer: Current Findings and Applications
    Dinh-Toi Chu et al, 2023, null CrossRef
56. Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients
    Aleksandra Kicman et al, 2022, Cancer Management and Research CrossRef
57. Epidemiology of cancers in women
    Saritha Vara et al, 2021, A Theranostic and Precision Medicine Approach for Female-Specific Cancers CrossRef
58. Hereditary Gynecologic Cancer Syndromes – A Narrative Review
    Stoyan Kostov et al, 2022, OncoTargets and Therapy CrossRef
59. Assessment of medical knowledge toward genetic testing for individuals with hereditary breast and ovarian cancer syndrome in Brazil
    João Lucas Lasta et al, 2023, Preventive Medicine Reports CrossRef
60. Patient-physician relationships, health self-efficacy, and gynecologic cancer screening among women with Lynch syndrome
    Kaitlin M. McGarragle et al, 2019, Hereditary Cancer in Clinical Practice CrossRef
61. A 25-Year-Old Woman Who Has Received a Letter from an Aunt Recommending Lynch Testing (Cascade Testing)
    Jessica M. Kingston, 2019, Office Gynecology CrossRef
62. Deciphering the Therapeutic Applications of Nanomedicine in Ovarian Cancer Therapy: An Overview
    Pooja Mathur et al, 2024, Current Drug Delivery CrossRef
63. Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment
    Karen Hoffmann et al, 2020, The EMBO Journal CrossRef